BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19067851)

  • 1. Pleomorphic carcinoma of the lung expressing podoplanin and calretinin.
    Kenmotsu H; Ishii G; Nagai K; Nakao M; Kawase A; Kojika M; Murata Y; Nishiwaki Y; Ochiai A
    Pathol Int; 2008 Dec; 58(12):771-4. PubMed ID: 19067851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D2-40-positive solitary fibrous tumors of the pleura: diagnostic pitfall of biopsy specimen.
    Naito Y; Ishii G; Kawai O; Hasebe T; Nishiwaki Y; Nagai K; Ochiai A
    Pathol Int; 2007 Sep; 57(9):618-21. PubMed ID: 17685935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin.
    Padgett DM; Cathro HP; Wick MR; Mills SE
    Am J Surg Pathol; 2008 Jan; 32(1):123-7. PubMed ID: 18162779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of podoplanin and calretinin in meningioma: an immunohistochemical study.
    Shintaku M; Honda T; Sakai T
    Brain Tumor Pathol; 2010 Apr; 27(1):23-7. PubMed ID: 20425044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.
    Buonaccorsi JN; Plaza JA
    Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
    Shield PW; Koivurinne K
    Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Two cases of pulmonary sarcomatoid carcinoma mimicking malignant mesothelioma].
    Inomata M; Kawagishi Y; Yamada T; Miwa T; Hayashi R; Kashii T; Matsui S; Fukuoka J; Tobe K
    Nihon Kokyuki Gakkai Zasshi; 2010 Jan; 48(1):33-8. PubMed ID: 20163019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry.
    Kushitani K; Takeshima Y; Amatya VJ; Furonaka O; Sakatani A; Inai K
    Pathol Int; 2008 Feb; 58(2):75-83. PubMed ID: 18199156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
    Ordóñez NG
    Hum Pathol; 2005 Apr; 36(4):372-80. PubMed ID: 15891998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cell-block immunocytochemical characterization of effusions. Use of antibody panel: calretinin, Ber-EP4, keratin and CD68].
    Lucchi I; Morigi F; Naldi S; Tabarri B; Elegibili E; Giangaspero F
    Pathologica; 1999 Dec; 91(6):447-52. PubMed ID: 10783640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sarcomatoid mesothelioma--a diagnostic challenge].
    Eiholm S; Meyer CN; Behrendt N
    Ugeskr Laeger; 2010 Sep; 172(39):2670-1. PubMed ID: 20920392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.
    Takeshima Y; Amatya VJ; Kushitani K; Kaneko M; Inai K
    Histopathology; 2009 May; 54(6):667-76. PubMed ID: 19438742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type.
    Gotzos V; Vogt P; Celio MR
    Pathol Res Pract; 1996 Feb; 192(2):137-47. PubMed ID: 8692714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement.
    Saad RS; Lindner JL; Lin X; Liu YL; Silverman JF
    Diagn Cytopathol; 2006 Dec; 34(12):801-6. PubMed ID: 17115439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High podoplanin expression in cancer cells predicts lower incidence of nodal metastasis in patients with lung squamous cell carcinoma.
    Suzuki H; Onimaru M; Koga T; Takeshita M; Yano T; Maehara Y; Nakamura S; Sueishi K
    Pathol Res Pract; 2011 Feb; 207(2):111-5. PubMed ID: 21194851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pseudomesotheliomatous carcinoma of the lung].
    Maeda R; Isowa N; Kawasaki Y; Tokuyasu H; Itakura A; Miura H; Onuma H
    Kyobu Geka; 2007 Jul; 60(7):555-8. PubMed ID: 17642217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcomatoid carcinoma of the lung presenting as a cutaneous metastasis.
    Terada T
    J Cutan Pathol; 2010 Apr; 37(4):482-5. PubMed ID: 19602061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podoplanin as a marker for mesothelioma.
    Kimura N; Kimura I
    Pathol Int; 2005 Feb; 55(2):83-6. PubMed ID: 15693854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma.
    Kushitani K; Takeshima Y; Amatya VJ; Furonaka O; Sakatani A; Inai K
    Pathol Int; 2007 Apr; 57(4):190-9. PubMed ID: 17316414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleomorphic carcinoma of the lung: clinicopathologic characteristics of 70 cases.
    Mochizuki T; Ishii G; Nagai K; Yoshida J; Nishimura M; Mizuno T; Yokose T; Suzuki K; Ochiai A
    Am J Surg Pathol; 2008 Nov; 32(11):1727-35. PubMed ID: 18769330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.